TY - JOUR
T1 - Health-care-associated infections in neonates, children, and adolescents
T2 - an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey
AU - Zingg, Walter
AU - Hopkins, Susan
AU - Gayet-Ageron, Angèle
AU - Holmes, Alison
AU - Sharland, Mike
AU - Suetens, Carl
AU - Almeida, Maria
AU - Asembergiene, Jolanta
AU - Borg, Michael A.
AU - Budimir, Ana
AU - Cairns, Shona
AU - Cunney, Robert
AU - Deptula, Aleksander
AU - Berciano, Pilar Gallego
AU - Gudlaugsson, Olafur
AU - Hadjiloucas, Avgi
AU - Hammami, Naïma
AU - Harrison, Wendy
AU - Heisbourg, Elisabeth
AU - Kolman, Jana
AU - Kontopidou, Flora
AU - Kristensen, Brian
AU - Lyytikäinen, Outi
AU - Märtin, Pille
AU - McIlvenny, Gerry
AU - Moro, Maria Luisa
AU - Piening, Brar
AU - Presterl, Elisabeth
AU - Serban, Roxana
AU - Smid, Emma
AU - Sorknes, Nina K.
AU - Stefkovicova, Maria
AU - Sviestina, Inese
AU - Szabo, Rita
AU - Tkadlecova, Hana
AU - Vatcheva-Dobrevska, Rossitza
AU - VerjatTrannoy, Delphine
N1 - Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Background In 2011–12, the European Centre for Disease Prevention and Control (ECDC) held the first Europe-wide point-prevalence survey of health-care-associated infections in acute care hospitals. We analysed paediatric data from this survey, aiming to calculate the prevalence and type of health-care-associated infections in children and adolescents in Europe and to determine risk factors for infection in this population. Methods Point-prevalence surveys took place from May, 2011, to November, 2012, in 1149 hospitals in EU Member States, Iceland, Norway, and Croatia. Patients present on the ward at 0800 h on the day of the survey and who were not discharged at the time of the survey were included. Data were collected by locally trained health-care workers according to patient-based or unit-based protocols. We extracted data from the ECDC database for all paediatric patients (age 0–18 years). We report adjusted prevalence for health-care-associated infections by clustering at the hospital and country level. We also calculated risk factors for development of health-care-associated infections with use of a generalised linear mixed-effects model. Findings We analysed data for 17 273 children and adolescents from 29 countries. 770 health-care-associated infections were reported in 726 children and adolescents, corresponding to a prevalence of 4·2% (95% CI 3·7–4·8). Bloodstream infections were the most common type of infection (343 [45%] infections), followed by lower respiratory tract infections (171 [22%]), gastrointestinal infections (64 [8%]), eye, ear, nose, and throat infections (55 [7%]), urinary tract infections (37 [5%]), and surgical-site infections (34 [4%]). The prevalence of infections was highest in paediatric intensive care units (15·5%, 95% CI 11·6–20·3) and neonatal intensive care units (10·7%, 9·0–12·7). Independent risk factors for infection were age younger than 12 months, fatal disease (via ultimately and rapidly fatal McCabe scores), prolonged length of stay, and the use of invasive medical devices. 392 microorganisms were reported for 342 health-care-associated infections, with Enterobacteriaceae being the most frequently found (113 [15%]). Interpretation Infection prevention and control strategies in children should focus on prevention of bloodstream infections, particularly among neonates and infants. Funding None.
AB - Background In 2011–12, the European Centre for Disease Prevention and Control (ECDC) held the first Europe-wide point-prevalence survey of health-care-associated infections in acute care hospitals. We analysed paediatric data from this survey, aiming to calculate the prevalence and type of health-care-associated infections in children and adolescents in Europe and to determine risk factors for infection in this population. Methods Point-prevalence surveys took place from May, 2011, to November, 2012, in 1149 hospitals in EU Member States, Iceland, Norway, and Croatia. Patients present on the ward at 0800 h on the day of the survey and who were not discharged at the time of the survey were included. Data were collected by locally trained health-care workers according to patient-based or unit-based protocols. We extracted data from the ECDC database for all paediatric patients (age 0–18 years). We report adjusted prevalence for health-care-associated infections by clustering at the hospital and country level. We also calculated risk factors for development of health-care-associated infections with use of a generalised linear mixed-effects model. Findings We analysed data for 17 273 children and adolescents from 29 countries. 770 health-care-associated infections were reported in 726 children and adolescents, corresponding to a prevalence of 4·2% (95% CI 3·7–4·8). Bloodstream infections were the most common type of infection (343 [45%] infections), followed by lower respiratory tract infections (171 [22%]), gastrointestinal infections (64 [8%]), eye, ear, nose, and throat infections (55 [7%]), urinary tract infections (37 [5%]), and surgical-site infections (34 [4%]). The prevalence of infections was highest in paediatric intensive care units (15·5%, 95% CI 11·6–20·3) and neonatal intensive care units (10·7%, 9·0–12·7). Independent risk factors for infection were age younger than 12 months, fatal disease (via ultimately and rapidly fatal McCabe scores), prolonged length of stay, and the use of invasive medical devices. 392 microorganisms were reported for 342 health-care-associated infections, with Enterobacteriaceae being the most frequently found (113 [15%]). Interpretation Infection prevention and control strategies in children should focus on prevention of bloodstream infections, particularly among neonates and infants. Funding None.
UR - http://www.scopus.com/inward/record.url?scp=85009488908&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(16)30517-5
DO - 10.1016/S1473-3099(16)30517-5
M3 - Article
C2 - 28089444
AN - SCOPUS:85009488908
SN - 1473-3099
VL - 17
SP - 381
EP - 389
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 4
ER -